Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 7 publications
Therapy for Stage IV Non-Small Cell Lung Cancer With Driver Alterations: ASCO Living Guideline, 2026.3.1.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: May 26, 2026
Therapy for Stage IV Non-Small Cell Lung Cancer Without Driver Alterations: ASCO Living Guideline, 2026.3.0.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: February 03, 2026
Therapy for Stage IV Non-Small Cell Lung Cancer With Driver Alterations: ASCO Living Guideline, 2026.3.0.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: February 03, 2026
Therapy for Stage IV Non-Small Cell Lung Cancer With Driver Alterations: ASCO Living Guideline, Version 2024.3.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: February 27, 2025
A Case of Angioimmunoblastic T-Cell Lymphoma and the Difficulties of Diagnosis.
Journal: Cureus
Published: September 02, 2023
Unraveling the Mystery of Gray Zone Lymphoma in Human Immunodeficiency Virus-Seropositive Patients: Two Cases.
Journal: Journal of hematology
Published: March 04, 2020
3'-Phosphoadenosine 5'-phosphosulfate synthase 1 (PAPSS1) knockdown sensitizes non-small cell lung cancer cells to DNA damaging agents.
Journal: Oncotarget
Published: November 19, 2014
Showing 1-7 of 7
Last Updated: 09/26/2026